scispace - formally typeset
J

Janet L. Maryanski

Researcher at Ludwig Institute for Cancer Research

Publications -  68
Citations -  4366

Janet L. Maryanski is an academic researcher from Ludwig Institute for Cancer Research. The author has contributed to research in topics: Antigen & CTL*. The author has an hindex of 34, co-authored 68 publications receiving 4326 citations. Previous affiliations of Janet L. Maryanski include Claude Bernard University Lyon 1 & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria

TL;DR: In this article, an epitope contained within amino acids 249-260 of the Plasmodium berghei circumsporozoite protein was identified by H-2Kd-restricted cytotoxic T cells.
Journal ArticleDOI

Obligatory Role for Cooperative Signaling by Pre-TCR and Notch during Thymocyte Differentiation

TL;DR: It is shown that pre-TCR signaling concurrent with Notch receptor and Delta-like-1 ligand interactions are required for the survival, proliferation, and differentiation of mouse CD4−CD8− thymocytes to the CD4+CD8+ stage.
Journal ArticleDOI

Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression.

TL;DR: Four different tumor-associated antigenic specificities were defined, each recognized by a specific CTL clone, one of which was absent from all escaping tumor cells and another had been lost by some of them.
Journal ArticleDOI

H—2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide

TL;DR: These anti-HLA CTL clones can lyse HLA-negative syngeneic mouse cells in the presence of a synthetic HLA peptide, suggesting that the model applies generally to viral proteins that are expressed internally and to antigens normally expressed as integral membrane proteins at the cell surface.
Journal ArticleDOI

CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria

TL;DR: Using P. yoelii specific ribosomal RNA probes to monitor the in vivo effects of the CTL clones, it was found that their target was the intrahepatocytic stage of the parasite.